Live tape
Top 8, mentions 7d15,265NVDA6,540 mentions▲ +0.04GOOGL1,864 mentions▲ +0.04SPY1,671 mentions▲ +0.05QQQ1,446 mentions▲ +0.05SPCX1,139 mentions▲ +0.06AMD950 mentions▲ +0.08MSFT842 mentions▲ +0.03CRWV813 mentions▲ +0.07

Equity · Healthcare

PTCT

NASDAQ

PTC Therapeutics (PTCT)

79 USD +0.55% vs prior close
PTC Therapeutics, Inc. price graph

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.

Track this symbol on TradingView
Market cap
6.6B USD
Revenue, year to Dec 2025
1.7B USD
EPS, diluted, year to Dec 2025
7.78 USD
52-week range
43.30 USD – 90 USD
Avg volume
368.2K

as of Jul 17, 2026

Have PTC Therapeutics (PTCT) insiders bought or sold shares recently?

In the 90 days to 11 Nov 2026, PTC Therapeutics insiders reported 15 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 10 Mar 2026, show no open-market purchase.

Form 4, 90 days to 11 Nov 2026, newest reported trade 14 Oct 2026

0buys
15sells
$7.75Mnet sold
5other filings
Have PTC Therapeutics (PTCT) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
14 Oct 2026SCHMERTZLER MICHAELDirectorSell2,500149K USD
09 Oct 2026Boulding Mark ElliottEXEC. VP AND CLOSell19212K USD
07 Oct 2026SCHMERTZLER MICHAELDirectorSell2,500158K USD
06 Oct 2026Boulding Mark ElliottEXEC. VP AND CLOSell43528K USD
05 Oct 2026Boulding Mark ElliottEXEC. VP AND CLOSell1,638105K USD
30 Sep 2026STEELE GLENN JR MD PHDDirectorSell12,000782K USD
17 Sep 2026SCHMERTZLER MICHAELDirectorSell10,000679K USD
16 Sep 2026SCHMERTZLER MICHAELDirectorSell10,000671K USD
10 Sep 2026SCHMERTZLER MICHAELDirectorSell10,000673K USD
09 Sep 2026SCHMERTZLER MICHAELDirectorSell10,000678K USD
27 Aug 2026SCHMERTZLER MICHAELDirectorSell12,500895K USD
26 Aug 2026SCHMERTZLER MICHAELDirectorSell12,500912K USD
Sold15 open-market sales112,078$7.75M

Showing the 12 most recent of 15 open-market trades in this window. The figures above count all of them.

5 other filings in the window: grants, exercises, tax withholding and transfers, not trades
Have PTC Therapeutics (PTCT) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
09 Oct 2026Boulding Mark ElliottEXEC. VP AND CLOOption exercise1928K USD
06 Oct 2026Boulding Mark ElliottEXEC. VP AND CLOOption exercise43517K USD
05 Oct 2026Boulding Mark ElliottEXEC. VP AND CLOOption exercise1,63865K USD
30 Sep 2026STEELE GLENN JR MD PHDDirectorOption exercise12,000135K USD
17 Aug 2026Boulding Mark ElliottEXEC. VP AND CLOOption exercise2,81372K USD

Which funds hold PTC Therapeutics (PTCT)?

1 of the 45 institutional funds we track reported a PTC Therapeutics position for the quarter ended 30 Sep 2026 — a combined 2.8M USD; the latest of those filings landed 06 Nov 2026.

Form 13F

Which funds hold PTC Therapeutics (PTCT)?
FundPositionSharesValueShares q/q
Fisher Asset ManagementHeld (±25%)43,0832.8M USD+5.8%

PTC Therapeutics (PTCT) US federal contracts

The most recent US federal contract to PTC Therapeutics (PTCT) is 175K USD from the Department of Veterans Affairs, signed 03 Nov 2026.

USAspending.gov

175KUSDfiscal 2027 so far
PTC Therapeutics (PTCT) US federal contracts
SignedAgencyContractCommitted
03 Nov 2026Department of Veterans AffairsSEPHIENCE (SEPIAPTERIN)ORAL POWDERDRUGS AND BIOLOGICALS · 36C26127F0038 · PTC THERAPEUTICS US, INC175K USD

Contracts of US$100,000 or more signed since April 2022; the amount is what the government has committed so far, which grows when options are exercised. Defense Department contracts are published about 90 days after signing, so the latest year is still filling in.

What has been filed or recorded for PTC Therapeutics (PTCT)?

The filings we hold for PTC Therapeutics, newest first: 1 fails-to-deliver day, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 09 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for PTC Therapeutics (PTCT)?
And
09 Oct 2026Fails to deliverShares failed to deliver6 shares375 USD notional · <0.001% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −0.62 USD
30 Sep 2026FinancialsTotal assets3.2B USDat period end
30 Sep 2026FinancialsTotal equity−191.2M USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS 0.92 USD
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.03 USD
31 Dec 2025Annual reportFY 2025 reportedEPS 7.78 USD
31 Dec 2025FinancialsRevenue1.7B USDfiscal year
31 Dec 2025FinancialsNet income682.6M USDfiscal year
31 Dec 2025FinancialsDiluted EPS7.78 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS 0.20 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.83 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS 10.04 USD
31 Dec 2024Annual reportFY 2024 reportedEPS −4.73 USD

What do people ask about PTC Therapeutics (PTCT)?

From live data
What is PTC Therapeutics’ market cap?6.6B

PTC Therapeutics is worth 6.6B USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.

What is PTC Therapeutics’ revenue?1.7B

PTC Therapeutics reported revenue of 1.7B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have PTC Therapeutics insiders bought or sold shares recently?15 sales

In the 90 days to 11 Nov 2026, PTC Therapeutics insiders reported 15 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 10 Mar 2026, show no open-market purchase. A further 5 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders

Which funds own PTC Therapeutics?1 of 45

1 of the 45 funds we track reported a PTC Therapeutics position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Fisher Asset Management. See Funds

When did PTC Therapeutics last report earnings?−0.62

PTC Therapeutics last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.62 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. USAspendingUSAspending.gov (U.S. Department of the Treasury), federal prime contract awards
  6. SECSEC fails-to-deliver (CNS) data
  7. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  8. SEC EDGARreported earnings figures and scheduled report dates
  9. SEC EDGARValuation computed from SEC EDGAR filings